Immunotherapy for recurrent malignant melanoma: efficacy of BCG in prolonging the postoperative disease-free interval and survival.

Subjects

Subjects :

BCG Vaccine administration & dosage
Dacarbazine therapeutic use
Humans
Melanoma drug therapy
Melanoma immunology
Melanoma mortality
Melanoma surgery
Neoplasm Recurrence, Local
Postoperative Complications
BCG Vaccine therapeutic use
Melanoma therapy

Details

Language :

English

ISSN :

0080-0015

Volume :

68

Database :

MEDLINE

Journal :

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer

Publication Type :

Academic Journal

Accession number :

752870

Full Text :

https://doi.org/10.1007/978-3-642-81332-0_53